The volume under the receiver operating characteristic surface (VUS) is useful for measuring the overall accuracy of a diagnostic test when the possible disease status belongs to one of three ordered categories. In medical studies, the VUS of a new test is typically estimated through a sample of measurements obtained by some suitable sample of patients. However, in many cases, only a subset of such patients has the true disease status assessed by a gold standard test. In this paper, for a continuous-scale diagnostic test, we propose four estimators of the VUS which accommodate for nonignorable missingness of the disease status. The estimators are based on a parametric model which jointly describes both the disease and the verification process. Identifiability of the model is discussed. Consistency and asymptotic normality of the proposed estimators are shown, and variance estimation is discussed. The finite-sample behavior is investigated by means of simulation experiments.
Introduction
For an ordinal three-category classification problem, the assessment of the performance of a diagnostic test is achieved by the analysis of the receiver operating characteristic (ROC) surface, which generalizes the ROC curve for binary diagnostic outcomes. The volume under the ROC surface (VUS) is a summary index, usually employed for measuring the overall diagnostic accuracy of the test. Under correct ordering, values of VUS vary from 1/6, suggesting the test is no better than chance alone, to 1, which implies a perfect test, i.e. a test that perfectly discriminates among the three categories. The theoretical construction of the ROC surface and VUS was introduced for the first time by Scurfield (1996) .
In medical studies, the evaluation of the discriminatory ability of a diagnostic test is typically obtained by making inference about its ROC surface and VUS, based on data from some suitable sample of patients (or units) . When the disease status of each patient can be exactly assessed by means of a gold standard (GS) test, a set of methods exist to estimate the ROC surface and VUS of the test in evaluation. See Nakas and Yiannoutsos (2004) , Xiong et al. (2006) , Li and Zhou (2009) and Kang and Tian (2013) , among others. In practice, however, disease status verification via GS test could be unavailable for all units in the sample, due to the expensiveness and/or invasiveness of the GS test. Thus, often, only a subset of patients undergoes disease verification. In such situations, the implementation of the methods discussed in the above mentioned papers could only be performed on the verified subjects, typically yielding biased estimates of ROC surface and VUS.
This bias is known as verification bias.
In order to correct for verification bias, the researchers often assume that the selection for disease verification does not depend on the disease status, given the test results and other observed covariates, i.e., they assume that the true disease status, when missing, is missing at random (MAR, Little and Rubin (2002) ). Under this assumption, there exist few methods to get bias-corrected inference in ROC surface analysis. Chi and Zhou (2008) proposed a nonparametric likelihood-based approach to obtain bias-corrected estimators for ROC surface and VUS of an ordinal diagnostic test. In case of continuous diagnostic tests, To Duc, Chiogna and Adimari (2016) discussed several solutions based on imputation and re-weighting methods, and proposed four verification biascorrected estimators of the ROC surface and VUS: full imputation (FI), mean score imputation (MSI), inverse probability weighting (IPW) and semi-parametric efficient (SPE) estimators.
However, in some studies the decision to send a subject to verification may be directly based on the presumed subject's disease status, or, more generally, the selection mechanism may depend on some unobserved covariates related to disease; in these cases, the MAR assumption does not hold and the missing data mechanism is called nonignorable (NI).
For two-class problems, methods to deal with NI verification bias have been developed, for instance, in Baker (1995) ; Zhou and Rodenberg (1998) ; Castelluccio (2003, 2004) ; Rotnitzky, Faraggi and Schisterman (2006); Fluss et al. (2009); Fluss, Reiser and Faraggi (2012); Liu and Zhou (2010) . However, the issue of correcting for NI verification bias in ROC surface analysis is very scarcely considered in the statistical literature. This motivated us to develop bias-corrected methods for continuous diagnostic tests with three-class disease status, under a NI missing data mechanism. In particular, in this paper we adopt parametric regression models for the disease and the verification processes, extending the selection model of Liu and Zhou (2010) to match the case of three-class disease status. Then, we use likelihood-based estimators of model parameters to derive four estimators of the VUS. Consistency and asymptotic normality of the proposed estimators are proved. Estimation of their variance is also discussed.
The rest of the paper is organized as follows. In Section 2, we set the working model and discuss its identifiability. In Section 3 we present our proposed bias-corrected VUS estimators, along with theoretical results about consistency and asymptotic normality. Moreover, variance estimation is also addressed. The results of a simulation study are presented in Section 4. Concluding remarks are left to Section 5.
2 Model for NI missing data mechanism 2.1 Background Suppose we need to evaluate the predictive ability of a new continuous diagnostic test in a context where the disease status of a patient can be described by three ordered categories, "non-diseased", "intermediate" and "diseased", say. Consider a sample of n subjects and let T , D and A denote the test result, the disease status and a vector of covariates for each subject, respectively. In this framework, D can be modeled as a trinomial random vector
a Bernoulli random variable having mean θ k = Pr(D k = 1) where θ 1 + θ 2 + θ 3 = 1. Hence, θ k represents the probability that a generic subject, classified according to its disease status, belong to the class k. We are interested in estimating the VUS of the test T , say µ, which is defined as (Nakas and Yiannoutsos (2004) )
or, equivalently,
where the indices i, , r refer to three different subjects, I i r = I(T i < T < T r ) + 1/2I(T i < T = T r ) + 1/2I(T i = T < T r ) + 1/6I(T i = T = T r ) and I(·) is the indicator function.
When the disease status D is available for all subjects, a natural nonparametric estimator of µ is given byμ
However, in many situations not all subjects undergo the verification process, and hence, the disease status D is missing in a subset of patients in the study. Let V i be the verification status for the i-th subject: V i = 1 if D i is observed and V i = 0 otherwise. We define the observed data as 
Model settings
To deal with NI missing data mechanism, in what follows we extend parametric models adopted in Liu and Zhou (2010) for the two-class problem to the three-class case. More precisely, with three disease categories, we fix the model for the verification process as follows
where D 1 and D 2 are defined in the previous section, h(T, A; τ π ) is, in general, an arbitrary working function, and τ π is a set of parameters. Here, λ = (λ 1 , λ 2 ) is the non-ignorable parameter: the missing data mechanism is MAR if λ 1 = λ 2 = 0; NI, otherwise. As for the disease model, we employ the multinomial logistic regression for the whole sample, i.e.,
where f (T, A; τ ρ k ) is an arbitrary working function, and τ ρ k is a set of parameters, for k = 1, 2.
The parameters λ, τ π , τ ρ , with τ ρ = (τ ρ 1 , τ ρ 2 ) , can be estimated jointly by using a likelihood-based approach.
It is worth noting that, under (3), an application of Bayes' rule gives that
Therefore,
so that, according to (5) and (6), λ 1 and λ 2 can also be interpreted as log-odds ratios of belonging to class 1 (instead of class 3) and to class 2 (instead of class 3), respectively, for a verified subject compared to an unverified subject with the same test result and covariates.
Parameter estimation
As in Liu and Zhou (2010) , in our model, for simplicity, we take h(T, A; τ π ) = τ π 1 +τ π 2 T +A τ π 3 and
, which is a natural choice in practice. For fixed T and A, the observed distribution is fully determined by the three probabilities Pr(
It is easy to show that
Similarly, we have that
and Pr(V = 0|T,
the log-likelihood function can be written as:
The estimatesλ,τ π , andτ ρ can be obtained by maximizing (λ, τ π , τ ρ ) or by solving the score
where
The above equations are obtained by using the following results
2 ) is a pair in the set {(1, 0), (0, 1), (0, 0)}), and
Identifiability
In this section, we verify that the working model based on (3), with h(T, A; τ π ) = τ π 1 +τ π 2 T +A τ π 3 , and (4), with f (T, A; τ ρ k ) = τ ρ 1k +τ ρ 2k T +A τ ρ 3k , is identifiable. Since the log-likelihood (7) is fully determined by the three probabilities Pr(
, we have to show that such probabilities are uniquely determined by the parameters for all possible T and A. For the sake of simplicity, in the remainder of this section the auxiliary covariate A is omitted (actually, we can always view A as fixed while varying T ).
Let x(t) = τ π 1 + τ π 2 t, y(t) = τ ρ 11 + τ ρ 21 t and z(t) = τ ρ 12 + τ ρ 22 t, for each t ∈ R. The above expressions, which refer to the quantities characterizing the the log-likelihood function (7), can be rewritten as log(ρ 3 π 00 ) = − log {1 + exp(y(t)) + exp(z(t))} + x(t) − log {1 + exp(x(t))} , log(ρ 1 π 10 ) = y(t) − log {1 + exp(y(t)) + exp(z(t))} + x(t) + λ 1 − log {1 + exp(x(t)) exp(λ 1 )} = log(ρ 3 π 00 ) + log {1 + exp(x(t))} + y(t) + λ 1 − log {1 + exp(x(t)) exp(λ 1 )} = log(ρ 3 π 00 ) + y(t) + log {1 + exp(x(t))} − log {exp(−λ 1 ) + exp(x(t))} = log(ρ 3 π 00 ) + y(t) + log 1 + exp(x(t)) exp(−λ 1 ) + exp(x(t)) ,
. Now, assume that there are two distinct points ξ and ξ * (ξ = ξ * ) in the parameter space, such that the following equations (with obvious notation) hold:
for all t ∈ R. By using (10), the equations (8) and (9) are equivalent to
respectively. In (11) and (12) the left hand sides are straight lines. Thus, in order to (11) and (12) hold for all t, the right hand sides must be constants. If these constants were 0 (because
, then (10) would no longer hold for ξ = ξ * and all t. Alternatively, the right hand sides of (11) and (12) are non-zero constants if τ π 2 = τ * π 2 = 0. Then, as a consequence, (10) still is valid, for ξ = ξ * and all t, eventually if τ ρ 21 = τ * ρ 21 = 0 and τ ρ 22 = τ * ρ 22 = 0. This allows us to state that: if Pr(D k |T ) = Pr(D k ), with k = 1, 2, then the considered model (with the particular choice for the functions h and f ) is identifiable, i.e., the joint probabilities Pr( 
Hence, we can get, in particular,
Clearly, we also may consider quantities as
Then, we observe that
Similarly, we have
so that (1) can be rewritten as
Equation (13) suggests how to build estimators of VUS when some disease labels are missing in the sample: we can use suitable estimatesρ ki to replace the D ki 's in (2). Therefore, a FI estimator of VUS is simplyμ
whereρ ki (k = 1, 2, 3 and i = 1, . . . , n) are the estimated disease probabilities obtained from the disease model (4). 
Here,π 10i = Pr(
Such estimates are derived from the verification model (3). Then, the MSI estimator of VUS iŝ
In the IPW approach, instead, each observation in the subset of verified units is weighted by the inverse of the probability that the unit was selected for verification. Thus, the IPW estimator
Clearly, the estimatesπ i also arise from the selection model (3).
The last estimator is the pseudo doubly robust (PDR) estimator. We define
An estimated version,D ki,PDR , is obtained by entering the estimatesπ i andρ k(0)i in the expression above. Then, the PDR estimator of VUS iŝ
The PDR estimator has the same nature as the SPE estimator discussed in To Duc, Chiogna and Adimari (2016) under MAR assumption. However, under NI missing data mechanism it no longer has the doubly robust property. In fact, correct specification of both the verification model and the disease model is required for the PDR estimator to be consistent.
Note that all VUS estimators basically require maximum likelihood estimates of the parameters λ, τ π and τ ρ of the working models (3) and (4).
Asymptotic behavior
Let ξ = (λ , τ π , τ ρ ) be the nuisance parameter. Observe that the proposed VUS estimators can be found as solutions of appropriate estimating equations (solved along with the score equations).
The estimating functions for FI, MSI, IPW and PDR estimators have generic term (corresponding to a generic triplet of sample units), respectively,
In the following, we will use the general notation G i r, * (µ, ξ), where the star stands for FI, MSI, IPW and PDR.
Recall that the nuisance parameter ξ is estimated by maximizing the log-likelihood function (7). Let S i (ξ) be the i-th subject's contribution to the score function, and I(ξ) = −E ∂ ∂ξ S i (ξ) the Fisher information matrix for ξ. To give general theoretical results, we assume standard regularity conditions, which ensure consistency and asymptotic normality of the maximum likelihood estimator ξ. Let µ 0 be the true VUS value, and ξ 0 = (λ 0 , τ 0π , τ 0ρ ) the true value of ξ. We also assume that:
is stochastically equicontinuous, where converges uniformly (in probability) to e * (µ, ξ) and ∂e * (µ,ξ) ∂ξ , respectively.
Then, we prove consistency and asymptotic normality of the proposed estimators.
Theorem 1 (Consistency). Suppose that conditions (C1)-(C3) hold, along with standard regularity
conditions for the likelihood function (as those given by Newey and McFadden (1994) Proof. We can show that E{G i r, * (µ 0 , ξ 0 )} = 0 (see the Appendix). Then e * (µ 0 , ξ 0 ) = 0, and, by condition (C2) and an application of implicit function theorem, there exists a neighborhood of ξ 0 in which a continuously differentiable function, m(ξ), is uniquely defined such that m(ξ 0 ) = µ 0 and e * (m(ξ), ξ) = 0. Since the maximum likelihood estimatorξ is consistent, i.e.,ξ p → ξ 0 , we have that
On the other hand, G * (μ * ,ξ) = 0 and condition (C3) implies that e * (μ * ,ξ)
Thus,μ * p →μ * .
Next we establish the asymptotic normality of the estimatorsμ * .
Theorem 2 (Asymptotic normality). Suppose the conditions in Theorem 1 are satisfied. If the verification model (3) and the disease model (4) hold, then
where the star indicates FI, MSI, IPW, PDR, and Λ * is a suitable value.
Proof. We have
Since e * (µ 0 , ξ 0 ) = 0, we get
Condition (C1) implies that the first term in right hand side of the last identity is o p (1). Using the Taylor expansion, we have
It is straightforward to show that
By standard results on the limit distribution of U-statistics (van der Vaart, 2000, Theorem 12.3,
where √ nG * (µ, ξ) is the projection of U n, * onto the set of all statistics of the form
for = i and r = , r = i. For the maximum likelihood estimatorξ, we can write
Hence, from (18),
Note that the observed data O i are i.i.d, then Q i, * (µ 0 , ξ 0 ) are also i.i.d. In addition, we easily show
Therefore, E{Q i, * (µ 0 , ξ 0 )} = 0, and
It is worth noting that the assumed regularity conditions for the likelihood and condition (C1)-(C3) hold in our working model, which is based on (3), with h(T, A; τ π ) = τ π 1 + τ π 2 T + A τ π 3 , and (4), with f (T, A; τ ρ k ) = τ ρ 1k + τ ρ 2k T + A τ ρ 3k .
Variance estimation
Under condition (C3), a consistent estimator of Λ * can be obtained aŝ
whereθ k, * are the estimates of the disease probabilities,
ki,PDR . According to (19), we have that
In addition, for fixed i, we also have that
The quantity
could be obtained as the Hessian matrix of the log likelihood function at ξ . In order to compute
, we have to get the derivatives
In Section 2.3, we obtain
where (d 1 , d 2 ) belongs to the set {(1, 0), (0, 1), (0, 0)}. Also, we have
with s = 1, 2. Then, recall that
.
second scenario, we generate the test result and the covariate from independent normal distributions.
Specifically, T i ∼ N (0.65, 1) and A i ∼ N (−0.3, 0.64). The disease status D i is generated according to model (4) with f (T, A; τ ρ 1 ) = 4.6 − 3.3T − 6.4A and f (T, A; τ ρ 2 ) = 4 − 1.7T − 3.2A. Then, V i
is obtained according to model (3) with h(T, A; τ π ) = 1 + 1.2T − 1.5A and λ 1 = −2.5, λ 2 = −1.
Under this setting, θ 1 = 0.55, θ 2 = 0.32, θ 3 = 0.13, and the verification rate is roughly 0.58. The true VUS value is 0.387. (2016)).
[ Table 1 about here]
Overall, simulation results are consistent with our theoretical findings and show the usefulness of the proposed estimators, which also arises from the comparison with the SPE estimator used improperly. The results also show a good behavior of the estimated standard deviations, which are generally close to the corresponding Monte Carlo values. In general, FI and MSI estimators seem to be more efficient than IPW and PDR estimators. However, for all estimators, acceptable bias levels and sufficiently accurate associated confidence intervals seem to require a large sample size (at least 500, and, prudently, even higher).
This issue of poor accuracy has already been noted by several authors, including Liu and Zhou (2010) , in the context of two-class classification problems. In our experience, the trouble appears to arise because of a bad behavior of the maximum likelihood estimates in the verification and disease models. If the sample size is not large enough, the data do not contain enough information to effectively estimate the parameters λ, τ π , τ ρ 1 and τ ρ 2 . It seems particularly difficult to get good estimates of nonignorable parameters. With larger sample size, this phenomenon almost completely vanishes, the maximum likelihood estimators behave pretty well, with a positive impact on the behavior of the VUS estimators.
[ Table 2 about here]
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Conclusion
In this paper, we have proposed four bias-corrected estimators of VUS under NI missing data mechanism. The estimators are obtained by a likelihood-based approach, which uses the verification model (3) together with the disease model (4). The identifiability of the joint model is proved, and hence, the nuisance parameters can be estimated by maximizing the log-likelihood function or solving the score equations. Consistency and asymptotic normality of the proposed FI, MSI, IPW and PDR estimators are established, and variance estimation is discussed.
The proposed VUS estimators are pretty easy to implement and require the use of some numerical routine to maximize the log-likelihood function (or to solve the score equations). Our simulation results show their usefulness, whilst confirming the evidence emerging in the two-class case, according to which a reasonable large sample size is necessary to make sufficiently accurate inference. In practice, among FI, MSI, IPW and PDR estimators, we would reccommend FI and MSI estimators thanks to their greater efficiency.
The poor accuracy problem seems to be related to an intrinsic difficulty of the maximum likelihood method in providing accurate estimates of the parameters of the disease and verification models, in particular of the nonignorable parameters. Overcoming this drawback is a stimulating challenge and deserves further investigation.
• PDR estimator.
Hence, Table 2 : Monte Carlo means (MCmean) for the maximum likelihood estimators of the elements of nuisance parameters λ, τ π , τ ρ 1 and τ ρ 2 .
Scenario I Scenario II True MCmean True MC mean n = 250 n = 500 n = 1500 n = 250 n = 500 n = 1500 
